Lipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy

Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499

Otvos, 2002, Why cholesterol measurements may be misleading about lipoprotein levels and cardiovascular disease risk—clinical implications of lipoprotein quantification using NMR spectroscopy, J Lab Med, 26, 544

Otvos, 2002, Measurement issues related to lipoprotein heterogeneity, Am J Cardiol, 90, 22i, 10.1016/S0002-9149(02)02632-2

Otvos, 1999, Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy, Clin Cardiol, 22, II21

Otvos, 1991, Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy, Clin Chem, 37, 377, 10.1093/clinchem/37.3.377

Otvos, 1992, Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement, Clin Chem, 38, 1632, 10.1093/clinchem/38.9.1632

Otvos, 1996, A spectroscopic approach to lipoprotein subclass analysis, J Clin Ligand Assay, 19, 184

Otvos, 2000, Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy, 609

Lounila, 1994, Effects of orientational order and particle size on the NMR line positions of lipoproteins, Phys Rev, 72, 4049

Redgrave, 1979, Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic men, J Lipid Res, 20, 217, 10.1016/S0022-2275(20)40633-9

McNamara, 1996, Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B, J Lipid Res, 37, 1924, 10.1016/S0022-2275(20)37557-X

Rainwater, 1997, Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins, J Lipid Res, 38, 1261, 10.1016/S0022-2275(20)37207-2

Blake, 2002, LDL particle concentration and size as determined by NMR spectroscopy as predictors of cardiovascular disease in women, Circulation, 106, 1930, 10.1161/01.CIR.0000033222.75187.B9

Groszek, 1978, Electron-microscopic evidence for particles smaller than 250 Å in very-low-density lipoproteins of human plasma, Atherosclerosis, 31, 241, 10.1016/0021-9150(78)90060-6

Rumsey, 1992, Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low-density lipoproteins, J Lipid Res, 33, 1551, 10.1016/S0022-2275(20)41409-9

Mora, 2006, LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA), Atherosclerosis

Garvey, 2003, The effects of insulin resistance and Type 2 diabetes mellitus on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance, Diabetes, 52, 453, 10.2337/diabetes.52.2.453

Kathiresan, 2006, Increased small LDL particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study, Circulation, 113, 20, 10.1161/CIRCULATIONAHA.105.567107

Goff, 2005, Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study, Metabolism, 54, 264, 10.1016/j.metabol.2004.09.002

Festa, 2005, Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study (IRAS), Circulation, 111, 3465, 10.1161/CIRCULATIONAHA.104.512079

Freedman, 2004, Sex and age differences in lipoprotein subclasses measured by Nuclear Magnetic Resonance spectroscopy: The Framingham Study, Clin Chem, 50, 1189, 10.1373/clinchem.2004.032763

Goldberg, 2005, A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with Type 2 diabetes and dyslipidemia, Diabetes Care, 18, 1547, 10.2337/diacare.28.7.1547

Rosenson, 2002, Relations of lipoprotein subclass levels and LDL size to progression of coronary artery disease in the PLAC I trial, Am J Cardiol, 90, 89, 10.1016/S0002-9149(02)02427-X

Otvos, 2006, LDL and HDL particle subclasses predict coronary events and are changed favorably by gemfibrozil therapy in the Veterans Affairs HDL Intervention Trial (VA-HIT), Circulation, 113, 1556, 10.1161/CIRCULATIONAHA.105.565135

Cromwell, 2004, Low-density lipoprotein particle number and risk for cardiovascular disease, Curr Atheroscler Rep, 6, 381, 10.1007/s11883-004-0050-5

Krauss, 1994, Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk, Curr Opin Lipidol, 5, 339, 10.1097/00041433-199410000-00005

Austin, 2000, Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype, Curr Atheroscler Rep, 2, 200, 10.1007/s11883-000-0021-4

Berneis, 2002, Metabolic origins and clinical significance of LDL heterogeneity, J Lipid Res, 43, 1363, 10.1194/jlr.R200004-JLR200

Lamarche, 1999, The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology, and therapeutic aspects, Diabetes Metab, 25, 199

McNamara, 1987, Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results of the Framingham Offspring Study, Arteriosclerosis, 7, 483, 10.1161/01.ATV.7.5.483

Austin, 1990, Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk, Circulation, 82, 495, 10.1161/01.CIR.82.2.495

Reaven, 1993, Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles, J Clin Invest, 92, 141, 10.1172/JCI116541

Sniderman, 2003, Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment, Lancet, 361, 777, 10.1016/S0140-6736(03)12663-3

Mackey, 2002, Lipoprotein subclasses and coronary artery calcification in postmenopausal women from the Healthy Women Study, Am J Cardiol, 90, 71i, 10.1016/S0002-9149(02)02636-X

Kuller, 2002, NMR spectroscopy of lipoproteins and risk of CHD in the Cardiovascular Health Study, Arterioscler Thromb Vasc Biol, 22, 1175, 10.1161/01.ATV.0000022015.97341.3A

Schaefer, 2004, LDL particle number, size, and subspecies in assessing cardiovascular risk: results from the Framingham Offspring Study, Circulation, 110

Post, 2002, LDL particle concentration and insulin level predict carotid atherosclerosis in high risk patients, JACC, 39, 274A, 10.1016/S0735-1097(02)81229-3

Deguchi, 2005, High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men, Circulation, 112, 893, 10.1161/CIRCULATIONAHA.104.521344

Haffner S, Williams K. LDL particles, small LDL particles, and LDL size by nuclear magnetic resonance are more related to metabolic syndrome components than are apoB and LDL size by gradient gel electrophoresis [abstract]. Presented at, January 2005 ADA Scientific Sessions; San Diego, CA.

Tallis, 1995, The total apolipoprotein B/LDL-cholesterol ratio does not predict LDL particle size, Clin Chim Acta, 240, 63, 10.1016/0009-8981(95)06131-6

Abate, 1993, Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100, Atherosclerosis, 104, 159, 10.1016/0021-9150(93)90187-Y